David MacDonald PhD - President
Dr David MacDonald has an over 25-year record of achievement in drug development and leadership of biotech companies achieving important technical milestones for those businesses and meeting critical corporate objectives.
Beth Cameron PhD - Vice President Clinical Development
Dr. Cameron is a Ph.D. scientist with over 20 years in the drug development industry. She has been at MSI since October 2012.
Dr Steven Targum MD - Chairman, Clinical Advisory Board
Dr Targum is widely regarded as an expert in the areas of protocol design, clinical trial methodologies, surveillance strategies, study analysis, and the progression of new drug candidates from concept to approval to launch.
Jay Kranzler M.D. Ph.D. - Executive Chairman and Chief Medical Officer
Dr Jay Kranzler is an acknowledged CNS clinical trial expert. Dr. Kranzler acts as an consultant and advisor to many companies, large and small. He has been presented the Award for Achievement by International Society of CNS Drug Development. Dr Kranzler has been involved in many development projects, with approvals in drugs (small molecules and biologics), devices, and diagnostics; 25 years as CEO of public biotech companies focused in areas of immunology, rheumatology, pain, and CNS.